Aanbevolen miekemuis.
Stukje uit dat dING van S. Bennett(pagina 6):
Acambis is competing with one other company, Bavarian Nordic, to win a US smallpox vaccine contract that could be worth up to US$ 900m. news on which could come before the end of the year.
Acambis has previously won a US$ 428 m. smallpox contract awarded by the US Government.
Acambis currently has a technology value of around 230 m. Euro, which we see as fair value.
(Acambis met veel koerswinst eruit en Crucell spotgoedkoop erin(ING-portefeuille) ...zou zo maar eens kunnen, nou ja, dat is ook weer mooi, kunnen we vanaf morgen weer terug richting "mijn" bodem van twintuuuug!
gr.